Dose Escalation Study in Acute Myeloid or B-Cell Acute Lymphoblastic Leukemia
Clinical trial NCT02215629 · WITHDRAWN
Trial details
- NCT number
- NCT02215629
- Sponsor
- Verastem, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Primary completion
- 2016-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.